208
Participants
Start Date
February 1, 2006
Primary Completion Date
July 1, 2010
Study Completion Date
March 1, 2011
ABI-007 (Abraxane)
30 minute infusions
bevacizumab
infusions
Center of Hope for Cancers and Blood, Stockbridge
Memorial Cancer Institute/Breast Cancer Center, Hollywood
Division of Hematology/Oncology University of Alabama at Birmingham, Birmingham
Little Rock Hematology Oncology Associates, Little Rock
California Oncology of the Central Valley, Fresno
Glendale Memorial Hospital & Health Center, Glendale
Front Range Cancer Specialists, Fort Collins
Palm Beach Institute of Hematology and Oncology, Boynton Beach
Florida Cancer Institute, Hudson
Hematology Oncology Associates, Lake Worth
Medical Specialist of the Palm Beaches, Inc, Lake Worth
Gulfcoast Oncology Associates, St. Petersburg
Peachtree Hematology & Oncology Associates, Atlanta
Northwest Georgia Oncology Centers, PC, Marietta
Maine Center for Cancer Medicine & Blood Disorders, Scarborough
Greater Baltimore Medical Center, Baltimore
Harbor View Cancer Center, Baltimore
Boston Medical Center Moakley Building, Solomont Center for Hematology & Medical Oncology, Boston
St. John's Mercy Medical Center, St Louis
Nebraska Methodist Hospital, Omaha
Drs. Forte, Schleidere, & Attas, PA, Englewood
Saint Barnabas Medical Center, Livingston
Monmouth Medical Center, Long Branch
Rosewell Park Cancer Institute Elm & Carlton Carlton Building, Buffalo
Beth Israel Comprehensive Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
NYU Clinical Cancer Center, New York
Marion L. Shepard Cancer Center, Washington
Medical Oncology Aultman Hospital, Canton
Cancer Centers of Southwest Oklahoma Research, Lawton
Abington Hematology Oncology, Willow Grove
Family Cancer Center, Collierville
Tennessee Cancer Specialists, Knoxville
TX Oncology, PA, Austin
South Texas Oncology & Hematology Clinical Research Dept., San Antonio
Virginia Commonwealth University Medical Oncology, Richmond
Swedish Cancer Institute, Seattle
Metropolitan Oncology Center, San Juan
Oncology Associates of Bridgeport, Bridgeport
North Shore Medical Cancer Center, Peabody
Lead Sponsor
Celgene
INDUSTRY